Testing by the National Medicines Institute showed non-compliance with quality requirements for the parameter "nitrosamine content: NDMA" and did not exclude NDMA contamination in product batches. Potential effects: exposure to a genotoxic nitrosamine, possible adverse effects and reduced safety of therapy.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
FAQ
Related